Because aberrant Gli activation has been implicated in many types of cancer, our findings that Ci/Gli activation is regulated by signal-induced kinase condensation and the formation of transcriptional complexes suggest that targeting these processes may provide avenues for cancer drug development. This evidence concerns the gene GLI1 and cancer.